| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |